ArticleBMC cancer2026

Retrospective analysis of high-dose-rate brachytherapy for patients with prostate cancer aged ≥ 75 years.

Keiji Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.